Cargando…

Vasoactive Drug Therapy and Clinical Nursing of Patients with Cardiovascular Disease

Cardiovascular disease (CVD) is a common human disease with a large number of patients. Vasoactive drugs have a good effect on the contraction and expansion of blood vessels, which can provide certain help for the management of cardiovascular diseases. However, the clinical care of cardiovascular di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Menglin, Xu, Meixiang, Feng, Minfang, Ren, Lingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519299/ https://www.ncbi.nlm.nih.gov/pubmed/36213559 http://dx.doi.org/10.1155/2022/5659513

Ejemplares similares

Weaning order of vasoactive drugs
por: Michels, Vilto, et al.
Publicado: (2019)

Response to “Weaning order of vasoactive drugs”
por: Jeon, Kyeongman, et al.
Publicado: (2019)

Modification by vasoactive drugs of tumour destruction by photodynamic therapy with haematoporphyrin derivative.
por: Cowled, P. A., et al.
Publicado: (1989)

Cerebral blood flow in critically ill cardiac patients: effects of vasoactive drug therapy
por: El-Atroush, H, et al.
Publicado: (2002)

Effects of vasoactive drugs on crystalloid fluid kinetics in septic sheep
por: Li, Yuhong, et al.
Publicado: (2017)

Hemodynamic profile and vasoactive drugs in acute respiratory distress syndrome
por: Wawrzeniak, IC, et al.
Publicado: (2003)

Clinical review: Influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock
por: Asfar, Pierre, et al.
Publicado: (2004)

Comparison of vasoactive-inotropic score, vasoactive-ventilation-renal score, and modified vasoactive-ventilation-renal score for predicting the poor prognosis after coronary artery bypass grafting
por: Du, Yanping, et al.
Publicado: (2023)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
por: Staines, Donald R, et al.
Publicado: (2009)

Vasoactive Hormones and the Diabetic Kidney
por: Maric, Christine
Publicado: (2008)

Vasoactive pharmacologic therapy in cardiogenic shock: a critical review
por: Kaddoura, Rasha, et al.
Publicado: (2021)

The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts
por: Kedia, George T., et al.
Publicado: (2020)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

What effect of vasoactive drugs on passive leg raising response in critically ill patients?
por: Alaya, S, et al.
Publicado: (2005)

Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases
por: Chen, Yao, et al.
Publicado: (2022)

Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation
por: Shukla, Ira, et al.
Publicado: (2021)

A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
por: Shankar, Aditi, et al.
Publicado: (2022)

Vasoactive and/or inotropic drugs in initial resuscitation of burn injuries: A systematic review
por: Knappskog, Kristine, et al.
Publicado: (2022)

Changeovers of vasoactive drug infusion pumps: impact of a quality improvement program
por: Argaud, Laurent, et al.
Publicado: (2007)

Dynamic subaortic stenosis with the use of vasoactive drugs in critical care: case report
por: Michels, V, et al.
Publicado: (2003)

Critical-Illness: Combined Effects of Colistin and Vasoactive Drugs: A Pilot Study
por: Stamatiou, Rodopi, et al.
Publicado: (2023)

The Vasoactive Mas Receptor in Essential Hypertension
por: Povlsen, Amalie L., et al.
Publicado: (2020)

Effect of vasoactive drugs on the response of the baroreceptor and regulation of heart rate variability in patients with septic shock
por: Nogueira, AC, et al.
Publicado: (2013)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
por: Wu, Dongmei, et al.
Publicado: (2011)

Penile Abscess Secondary to Neglected Penile Fracture after Intracavernosal Vasoactive Drug Injection
por: Song, Wan, et al.
Publicado: (2012)

Angioedema Caused by Drugs That Prevent the Degradation of Vasoactive Peptides: A Pharmacovigilance Database Study
por: Noguchi, Yoshihiro, et al.
Publicado: (2021)

Hemodynamic impact of early mobilization in critical patients receiving vasoactive drugs: A prospective cohort study
por: Borges, Larissa Faria, et al.
Publicado: (2022)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

Splanchnic Haemodynamics and Vasoactive Agents in Experimental Cirrhosis
por: Geraghty, J. G., et al.
Publicado: (1994)

The Vasoactive Potential of Kisspeptin-10 in the Peripheral Vasculature
por: Sawyer, Iain, et al.
Publicado: (2011)

Epinephrine: Is it really the black sheep of vasoactive agents?
por: Agrawal, Ritwick, et al.
Publicado: (2010)

Involvement of vasoactive substances in hemodynamics disturbances in cirrhosis
por: Grancea-Iancu, M
Publicado: (2014)

Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney
por: Rukavina Mikusic, N. L., et al.
Publicado: (2016)

Treating Hypotension in Preterm Neonates With Vasoactive Medications
por: Joynt, Chloe, et al.
Publicado: (2018)

Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis*
por: McIntosh, Amanda M., et al.
Publicado: (2017)

Distribution and relative expression of vasoactive receptors on arteries
por: Liu, Xinhao, et al.
Publicado: (2020)

Vasoactive Effects of Acute Ergot Exposure in Sheep
por: Yonpiam, Rossalin, et al.
Publicado: (2021)

Cardiac pericytes function as key vasoactive cells to regulate homeostasis and disease
por: Lee, Linda L., et al.
Publicado: (2020)

Clinical Rehabilitation Nursing of Patients with Chronic Obstructive Pulmonary Disease Based on Intelligent Medicine
por: Zhao, Lingyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6irl7ndubrb175ugnau06v07di